Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)
Clinical trial NCT00242320 · COMPLETED
Trial details
- NCT number
- NCT00242320
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-05-01
- Enrollment
- 551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.